Latest DEF 14A proxy statements

Remitly Global, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation disclosures.

Climb Bio, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and proposed amendments to its certificate of incorporation and equity incentive plan.

Harmonic Inc. has issued its 2026 proxy statement, detailing proposals for director elections, executive compensation, and an increase in equity incentive plan shares.

GPGI, Inc. announces its virtual Annual Meeting on June 11, 2026, where stockholders will vote on director elections, executive compensation, and auditor ratification, following significant corporate governance and ownership changes.

Evolent Health's 2026 proxy statement outlines executive compensation adjustments, board refreshment, and a proposal to increase shares under its incentive plan following a challenging 2025.

Keurig Dr Pepper announces strong 2025 performance, the acquisition of JDE Peets, and a planned separation into two independent companies.

Xponential Fitness, Inc. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on May 20, 2026.

Serve Robotics Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026.

GCM Grosvenor Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 9, 2026.

Sarepta Therapeutics is seeking shareholder approval for new 2026 equity and stock purchase plans while managing a leadership transition following the announced retirement of CEO Douglas Ingram.

SkinHealth Systems Inc. has issued its 2026 proxy statement, detailing director elections, executive compensation, and ongoing legal proceedings.

CRA International, Inc. has issued its proxy statement for the 2026 annual meeting of shareholders to be held on July 16, 2026.

Lifecore Biomedical, Inc. has filed its 2026 proxy statement, outlining proposals for director elections, auditor ratification, executive compensation, and a new 2026 Stock Incentive Plan.

Pegasystems Inc. has released its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation plans.

Block, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation proposals.

Greenlight Capital Re, Ltd. announces its 2026 Annual General Meeting to elect directors, ratify auditors, and conduct an advisory vote on executive compensation.

10x Genomics announces its 2026 Annual Meeting of Stockholders to be held virtually on June 4, 2026.

Applied Optoelectronics, Inc. has released its 2026 proxy statement detailing proposals for the upcoming annual meeting, including director elections, executive compensation, and a new equity incentive plan.

Outset Medical has released its 2026 proxy statement detailing director elections, executive compensation, and the ratification of its independent auditor.

Willis Lease Finance Corporation announces its 2026 Annual Meeting, proposing a 3-for-1 forward stock split and executive compensation approvals.

Fractyl Health announces its 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026.

Arcturus Therapeutics has issued its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification.

IRIDEX Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 12, 2026.

Coinbase Global, Inc. has issued its 2026 proxy statement detailing the upcoming virtual annual meeting, director elections, and executive compensation practices.

Globus Medical, Inc. has filed its 2026 proxy statement detailing the upcoming annual meeting agenda, including director elections and an equity incentive plan amendment.

Fate Therapeutics' 2026 proxy statement outlines director elections, auditor ratification, executive compensation, and a proposal to increase the 2022 Stock Option and Incentive Plan share reserve by 7 million shares.

Arlo Technologies reports strong 2025 financial growth driven by its subscription-based security model, with management seeking shareholder approval for director elections and executive compensation.

Interactive Strength Inc. announces its 2026 Annual Meeting of Stockholders to vote on director elections, share issuances, and a potential reverse stock split.

Columbia Sportswear seeks shareholder approval to double its stock incentive pool following a fiscal year marked by a 24% decline in operating income.

Caribou Biosciences has issued its 2026 proxy statement, outlining director elections, auditor ratification, and a proposal to amend its certificate of incorporation to provide officer exculpation.